-
Product Insights
Primary Ciliary Dyskinesia – Drugs In Development, 2023
Global Markets Direct’s, ‘Primary Ciliary Dyskinesia - Drugs In Development, 2023’, provides an overview of the Primary Ciliary Dyskinesia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Primary Ciliary Dyskinesia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Bronchiectasis – Drugs In Development, 2023
Global Markets Direct’s, ‘Bronchiectasis - Drugs In Development, 2023’, provides an overview of the Bronchiectasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bronchiectasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Report Bundle
51% offAerospace (Air and Warfare) – Report Bundle (6 Reports)
“With modern-day conflicts, the world has noticed a transition in the aerospace domain. From hypersonic cruise missiles striking critical infrastructure to accurate artillery and drone strikes, the domain of aerospace is observing a tectonic shift through innovations. With this, defense expenditure in this domain is also projected to rise. With the creation of defense wings like the space force, the integration of new anti-satellite systems, and the introduction of anti-drone techs, the aerospace realm is exploring new ways to outshine...
-
Product Insights
Bronchiectasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Bronchiectasis is a chronic condition where the walls of the bronchial tubes are permanently damaged. This damage allows bacteria and mucus to build up in the lungs. Bronchiectasis is divided into two categories cystic fibrosis (CF) bronchiectasis and non-CF bronchiectasis. Symptoms include chronic coughing, shortness of breath, chest pain, fatigue, weight loss, and fever. The Bronchiectasis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Bronchiectasis, Â complete with analysis by stage of development, drug target,...